The antimicrobial susceptibility testing market is experiencing significant growth, with a projected value of USD 8.45 billion by 2032, exhibiting a CAGR of 6% throughout the forecast period. In 2022, the market was valued at USD 4.24 billion. The escalating prevalence of infectious diseases such as HIV, malaria, tuberculosis, and others is a key driving factor behind the increasing demand...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian